Glaukos Corporation · 11 hours ago
Cornea Reimbursement Liaison
Glaukos Corporation is seeking a Reimbursement Liaison to serve as an expert in reimbursement policies and patient support. The role involves educating healthcare providers on clinical documentation, treatment approvals, and billing practices to ensure patient access to their sight-saving technologies.
Health CareMedicalWellness
Responsibilities
Provides HCPs and their office staff education on how to interpret benefit verifications including PA requirements, calculation of patient cost share and drug acquisition options for specific patients enrolled in GPS
Collaborates with Patient Support Specialist (PSS) to identify and eliminate barriers to access for patients enrolled in GPS
Responds to HCP questions related to coding, payer policy, and approval protocols
Offers expertise on navigating copay assistance for appropriate patients enrolled in GPS
Provides education on navigating the appeals process as well as denied and partially paid claims
Takes lead in completing Business Reviews and Claims Reviews for practices
Provides education on specialty pharmacy and buy & bill acquisition options
Monitors reimbursement trends (e.g., HCPs receiving notification of policy changes, claim denials, underpayments, etc.) and engages payer team appropriately when patient access may be jeopardized
Maintains expertise in regional and national payer landscapes, specifically, proper clinical requirements, reimbursement policy, utilization management criteria, prior authorization processes and appeal requirements
Updates customers on policy changes through approved templates and plan approval
Identifies coverage gaps and computer errors on policy requirements or portal entry challenges that inhibit patient access to care
Manages all forms of communication in a timely and professional fashion to ensure customer needs are fully met and all relevant internal stakeholders are appropriately updated
Demonstrates positive leadership, without authority, to peers, upper management and other stakeholders by leveraging skills and expertise in account management
Successfully completes assigned training
The Reimbursement Liaison consistently demonstrates uncompromised ethics and integrity while helping others understand legal and regulatory parameters related to anti-kickback statutes, fraud and abuse, off-label promotion, and OIG guidance related to patient assistance programs
Qualification
Required
Bachelors Degree in related field
8 plus years of experience working with specialty pharmaceuticals or surgical devices required
Minimum of 3 years 'direct' reimbursement/healthcare policy experience required
Ability to travel adequately to cover territory, as well as overnight travel (~50%) and attendance at scheduled training and meetings
Proven record of accomplishment in achieving objectives and corporate goals with minimal direct supervision
Demonstrated creativity, situation analysis/problem solving skills and analytical skill ability
Excellent communication skills, including written, verbal and listening
Strong presentation and training skills
Demonstrated leadership and project management skills
Significant experience working with a Patient Service Center/Hub
Successful navigation of complex authorization processes for specialty medications, Orphan, or Rare disease
Educate Healthcare Professionals on the availability of patient support programs such as Co-Pay Assistance and Patient Assistance Programs
Preferred
MBA or MPH preferred
Previous sales, district management, field reimbursement, hospital or practice experience preferred
Eyecare experience preferred
Reimbursement experience with physician-administered injectables and/or medical devices, Category III CPT codes and/or miscellaneous J-codes, specialty pharmacy and buy & bill acquisition, and benefit verifications, prior authorizations, claims assistance, and appeals
Payer/insurance coverage experience with Medicare, Medicare Advantage, VA/Tri-Care, Commercial and Medicaid plans
Company
Glaukos Corporation
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
Funding
Current Stage
Public CompanyTotal Funding
$121MKey Investors
Meritech Capital PartnersOrbiMed
2015-06-25IPO
2013-02-07Series F· $30M
2012-10-03Debt Financing· $6M
Leadership Team
Recent News
Orange County Business Journal
2026-01-22
thefly.com
2026-01-16
Company data provided by crunchbase